Terumo Medical Corporation Overview
Company Headquarters: Tokyo, Japan
Founded: 1921
Workforce: 25,000
Company Working: Terumo Medical Corporation delivers innovative health solutions and provides breakthrough solutions and technologies. The company is involved in manufacturing and sales of medical products and equipment, such as pharmaceuticals, nutritional food supplements, disposable medical devices, vascular grafts, and blood glucose monitoring systems, among others. It has a market presence in over 160 countries in the world. It operates its business through three segments, namely, cardiac and vascular company, blood management company, and general hospital company. Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies. TIS offers a complete, solution-based product portfolio used in advanced coronary, peripheral endovascular and urological treatments with strategic initiatives in Transradial Access, Complex Coronary Intervention, Peripheral Artery Disease and Embolotherapy.
Strategy
Terumo Medical Corporation focuses on developing technologically advanced products. The company aims to maintain and enhance customer satisfaction by providing quality products and improving customer support and services. Moreover, with ongoing and past acquisitions, it aims to acquire a high level of expertise and organizational capabilities to engage in mergers and acquisitions outside Japan. Also, in current years, the company is focused on increasing the production capacity of its products in the TIS division. For instance, the company is progressively investing to increase its production capacity for intervention products at the Vietnam factory to respond to growing demand in countries, such as China and India.
